Jiangsu Hengrui Medicine
600276.SS
£6.66
Share price
2.84%
Change (1 day)
53.15%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
EPS for Jiangsu Hengrui Medicine (600276.SS)
EPS in 2025 (TTM): £0.10
According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is £0.09590. In 2024 the company made an earnings per share (EPS) of £0.10 an increase over its 2023 EPS that were of £0.07204.
EPS history for Jiangsu Hengrui Medicine from 2000 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | £0.10 | -2.33% |
| 2024 | £0.10 | 42.43% |
| 2023 | £0.07204 | 8.77% |
| 2022 | £0.06623 | -20.62% |
| 2021 | £0.08343 | -26.59% |
| 2020 | £0.11 | 27.24% |
| 2019 | £0.08933 | 28.41% |
| 2018 | £0.06956 | 20.04% |
| 2017 | £0.05795 | 31.21% |
| 2016 | £0.04416 | 11.46% |
| 2015 | £0.03962 | 36.27% |
| 2014 | £0.02908 | 19.77% |
| 2013 | £0.02428 | 18.05% |
| 2012 | £0.02057 | 23.9% |
| 2011 | £0.01660 | 26.9% |
| 2010 | £0.01308 | 12.37% |
| 2009 | £0.01164 | 56.6% |
| 2008 | £0.007433 | 9.18% |
| 2007 | £0.006808 | 114.48% |
| 2006 | £0.003174 | 64.83% |
| 2005 | £0.001926 | 35.55% |
| 2004 | £0.001421 | 29.73% |
| 2003 | £0.001095 | 19.86% |
| 2002 | £0.0009137 | -2.71% |
| 2001 | £0.0009392 | 1.02% |
| 2000 | £0.0009297 |